MICHELLE HAUSER: Open Payments
NPI 1164436374 · PLATTEVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 48 payments from 11 companies in 2025. Trend: 2023 $1,258 · 2024 $880 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $263 |
| PFIZER INC. | 10 | $180 |
| Dexcom, Inc. | 6 | $125 |
| Novo Nordisk Inc | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: VRAYLAR, NURTEC ODT, Dexcom G6 Transmitter, Ozempic, CAPLYTA, MOUNJARO, JARDIANCE, UBRELVY.
Industry payments across WI — which companies pay providers there.
